Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ionis Pharmaceuticals Inc (NASDAQ:IONS)

29.69
Delayed Data
As of Aug 30
 -0.63 / -2.08%
Today’s Change
19.59
Today|||52-Week Range
65.34
-52.06%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues49.1M51.6M36.9M38.5M
 
 
 
 
 
Depreciation And Amortization2.6M2.6M2.2M2.3M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses94.6M111.9M88.9M85.0M
 
 
 
 
 
Research And Development88.0M100.0M80.5M77.4M
 
 
 
 
 
Total Operating Expenses97.3M114.5M91.1M87.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-48.1M-62.9M-54.3M-48.8M
 
 
 
 
 
Extraordinary Charge0.000.00-400.0K-100.0K
 
 
 
Interest Expense On Debt9.2M9.4M9.5M9.6M
 
 
 
 
 
Other Expenses20.4M-125.0K0.000.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-35.8M-71.1M-62.7M-57.1M
 
 
 
 
 
Income Taxes0.00-372.0K-232.0K-231.0K
 
 
 
 
Net Income-35.8M-71.4M-62.9M-56.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS120.0M120.2M120.6M120.8M
 
 
 
 
 
Shares To Calculate EPS Diluted120.0M120.2M120.6M120.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.30-$0.59-$0.52-$0.47
 
 
 
 
 
EPS Diluted-$0.30-$0.59-$0.52-$0.47